The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients - Trial NCT05855278
Access comprehensive clinical trial information for NCT05855278 through Pure Global AI's free database. This phase not specified trial is sponsored by Chang Gung Memorial Hospital and is currently Completed. The study focuses on Esophageal Cancer. Target enrollment is 22 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Chang Gung Memorial Hospital
Timeline & Enrollment
N/A
Aug 13, 2019
Jun 30, 2022
Primary Outcome
Overall survival
Summary
PET/MRI has the advantage to assess the metabolism, diffusion, and perfusion parameters of
 the tumor simultaneously and has been investigated in some cancers with promising results. In
 this study, we prospectively investigate the role of PET/MRI in evaluating the outcome of
 patients with esophageal cancer treated by definitive chemoradiotherapy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05855278
Non-Device Trial